Dietary mix-product

FIELD: food industry.

SUBSTANCE: invention is related to processing agricultural products and intended for application in dietary alimentation. The dietary mix-product, according to the invention, includes biological active components as follows: oatmeal - 94.0-95.0 wt %, powder from dry stevia leaves - 1.5-2.0 wt %, "Biobakton" and "dry Bifidumbacterin" lyophilisate (at a ratio of 1:4) - 1.5-2.0 wt %, the rest is water.

EFFECT: oatmeal introduction into a dietary product composition allows to increase the protein part by 10,8%; stevia leaves powder replenishes the carbohydrate part of the product with a low-caloric digestible vegetable biologically active complex, probiotics recover the bowel normobiocenosis.

6 tbl, 4 ex

 

The technical FIELD TO WHICH the INVENTION RELATES.

The invention relates to the production, processing and biotechnology of agricultural products, is intended for use in dietary and creation of biotechnological methods for functional foods new generation.

The LEVEL of TECHNOLOGY

Known technical culture of stevia (Stevia Rebaudiana Bertoni)leaves which contain fiber, fat, protein, carotene, calcium, trace elements, amino acids and biological extractives (stevioside complex).

Herbal Supplement - the leaves of stevia enrich the product of natural biologically active substances, micro and macronutrients, essential sulfur-containing amino acids, mineral substances. The dry leaves of stevia, THE 9729-003-00668620-06, are recommended for use as a dietary Supplement for diet products.

1. The dry leaves of stevia, THE 9729-003-00668620-06, are recommended for use as a dietary Supplement for diet products.

2. Genavieve and other Dietary products based on stevia. J. "Food industry", No. 5, 2005

3. Polanski K.K. Stevia products curative and preventive purposes. J. "Food industry", No. 5, 2005

Priority in addition to the Noah of science in the development of new functional food products is the use of probiotics, containing highly concentrated immunobiological biologically active preparations - lipidogram. Cm. Geenwich and other new product Behibak and study its effect on cytokine production. Biotechnology, 2008, No. 1, p.64-71, or in the form of immunobiological preparation "Bifidumbacterin dry lyophilisate" Fund 42-0092-2847-02, certificate of compliance No. 000452, OKP 01897209 produced by FSUE "NPO "Microgen" health Ministry.

Well-known dietary Supplement containing Lactobacillus Lb. Acidophilus up to 109bacterial cells Lb. Acidophilus, strain 12 b in the form of BAD Beobachten THE 9229-054-07532800-2005. They have antagonistic activity against a wide spectrum of pathogenic and conditionally pathogenic micro-organisms in the intestines and create favorable conditions for the development of microflora and functions of the digestive tract, and metabolic processes.

Representative of useful microflora are the bifidobacteria group Bifidobacterium bifidum. They have bifidogenic effect and provide the activation of the immune system, the formation of non-specific immune bodies, reduce the pH of the gut contents, create unfavorable conditions for the development of pathogenic microflora. Bifidobacteria are presented in the form of immunobiological preparation "Bifidumbacterin dry lyophilisate" Fund 42-0092-2847-02, certificate of compliance No. 000452, OKP 01897209 produced by FSUE "NPO "Microgen" health Ministry.

Sharing Lactobacillus Lb. Acidophilus in the form of SUPPLEMENTS "Beobachten" and bifidobacteria group Bifidobacterium bifidum in the form of "Bifidumbacterin dry lyophilisate for dietary supplements provides the following benefits: the fortification of biologically active probiotic microorganisms in combination with herbal SUPPLEMENTS.

Known and the effectiveness of the use of SUPPLEMENTS "Beobachten" and "Bifidumbacterin dry lyophilisate in a ratio of 1:4 on pigs hypotropia (Cm. the dissertation on competition of a scientific degree of candidate of agricultural Sciences Rastvorov Yevgeny Ivanovich, Stavropol, 2007, and the patent of the Russian Federation No. 2330412, Feed additive for piglets of lipotropics).

The closest in technical essence and the achieved positive effect and adopted by the authors for the prototype is a Method for oat pudding, which involves the use of crushed grain oats with shells that fill with water to obtain a suspension and add to fermentation Bifidumbacterin dry or a mixture of Bifidumbacterin and Lactobacterin dry in equal parts in the ratio of 0.2-0.4 dose of bacteria in 1 l of water at 30-37°C. Then the suspension is separated shells, fill them with a solution containing a mixture of whey and water in the ratio 1:3 or 1:2 and preparing decoction. The remainder of cook on the receiving castelobranco mass and mixed with broth at 90-100°C to obtain pudding (see patent No. 2218814, CL A23L 1/00, A23L 1/05, A23C 21/00).

The disadvantage of this method is that when cooking oatmeal pudding is the complexity of the technology and is used only one herbal Supplement grain oats.

DISCLOSURE of INVENTIONS

The task of the invention is to develop a diet product-mix, containing biologically active probiotic and herbal supplements that improve carbohydrate metabolism, stimulates the enzymatic activity.

The technical result that can be obtained using the present invention is that the introduction of the product biologically active components consisting of a powder of the leaves of the stevia plant, which includes components of fat, protein, fiber, NFE, amino acids and trace elements, etc. for the activation of the protein-carbohydrate metabolism and refilling with fats, proteins, sulfur-containing amino acids (methionine + cystine + lysine) and micronutrients and probiotics in a certain ratio, which restores normalizes intestines, stimulates the motility of the gastrointestinal tract, increase the body's resistance and immunity.

The technical result is achieved by using components, including oat flour, powder of dry leaves of stevia, which is mixed in dry form, said the with water at a temperature of 90-100°C, biologically active additives in the form of SUPPLEMENTS "Beobachten" and lyophilized Bifidumbacterin, which are mixed in a ratio of 1:4 at a temperature of 37°C.

The essence of the invention consists in the following:

Diet product mix, including oatmeal and water, contains powder of dry leaves of stevia, BAD "Beobachten" and Bifidumbacterin (ratio 1:4) in the following ratio, wt.%:

Oatmeal94,0-95,0
Powder of dry leaves of stevia1,5-2,0
BAD "Beobachten" and Bifidumbacterin
(ratio 1:4)1,5-2,0
WaterRest

Tests of the invention have shown that the proposed diet product compensates for the shortage of vegetable biogenic component, mineral, protein and vitamin substances, sulfur-containing amino acids, necessary for the correction of biobalance, improve the nutritional and biological value and digestibility of the product.

The IMPLEMENTATION of the INVENTION

Examples of specific performance cooking diet product mix.

Example 1. Propagatable diet product mix mix the following components, wt.%:

Oatmeal93,0
Powder of dry leaves of stevia1,0
BAD "Beobachten" and "Bifidumbacterin dry"
The lyophilisate (ratio 1:4)2,5
Water3,5

Taste, smell and color of the diet product mix peculiar diet product with the sugary taste of the leaves of stevia, probiotics and oat flour, correspond to the indicators in table 1.

Example 2. Cooking diet product mix is carried out analogously to example 1, mix the following components, wt%:

Oatmeal94,0
Powder of dry leaves of stevia1,5
BAD "Beobachten" and "Bifidumbacterin dry"
The lyophilisate (ratio 1:4)2,0
Water2,5

Taste, smell and color of the diet product m is CA - typical diet product with less sugary taste of the leaves of stevia, probiotics and oat flour, correspond to the indicators in table 1.

Example 3. Cooking diet product mix is carried out analogously to example 1, mix the following components, wt%:

Oatmeal95,0
Powder of dry leaves of stevia2,0
BAD "Beobachten" and "Bifidumbacterin dry"
The lyophilisate(ratio 1:4)1,5
Water1,5

Taste, smell and color of the diet product mix peculiar diet product with a slight taste of the leaves of stevia, probiotics and oat flour, correspond to the indicators in table 1.

Example 4. When cooking dry diet product mix mix the following components, wt%:

Oatmeal96,0
Powder of dry leaves of stevia1,0
BAD "Beobachten" and "Bifidumbacterin dry the th"
The lyophilisate (ratio 1:4)2,5
Water0,5

Taste, smell and color of the diet product MIK-peculiar diet product with a slight taste of the leaves of stevia, probiotics and oat flour, correspond to the indicators in table 1.

According to the results of organoleptic properties and nutritional value (see table 1) are optimal choices diet product mix in examples 2,3.

Use oat flour as the main ingredient in combination with probiotics improves the taste of diet product mix, using powder of dry leaves of stevia.

Table 1
Organoleptic indicators of diet product mix
IndicesExample 1Example 2Example 3Example 4
AppearancePowderPowderPowderOn osok
ColorLight brown with greenish patchesLight brown with greenish patchesLight brown with greenish patchesLight brown with greenish patches
SmellTypical oat flour and stevia leafTypical oat flour and stevia leafTypical oat flour and stevia leafTypical oat flour and stevia leaf
TasteTypical diet product with a cloying aftertaste stevia leafTypical diet product with less cloying aftertaste stevia leafTypical diet product with the taste of stevia leafTypical diet product with a slight taste of stevia leaf
Nutritional value, kcal328,0331,8339,8338,16

BIOLOGICALLY ACTIVE COMPONENTS IS YOU

DIET PRODUCT-MIX

For partial replacement of missing biologically active substances that stimulate the growth, development and activity of the organism, as well as normalization of biocenosis, you must use the biologically active components of milk and vegetable origin.

The leaves of stevia (powder)

Characteristics and composition of the new cultivated sugariness technical culture - honey herb - Stevia (Stevia Rebaudiana Bertoni) and components processed stevia leaf (TU 9729-003-00668620-06) - potential biologically active plant components for diet products are shown in tables 2, 3, 4, 5, 6.

Table 2
Organoleptic characteristics of dry leaves of stevia (powder)
IndicesCharacterization and Norma
AppearanceMixture of leaves, stems, buds and flowers, pieces of thin stems with a particle size of from 0.4 to 4 mm
The color of the leaf and stemsFrom light green to green. Pets color from yellow to brown
Smell/td> Weak specific raw materials, no odor
TasteIntensely sweet, with bitter taste

Physico-chemical characteristics of dry leaves of stevia meet the requirements specified in table 3.

Table 3
Physico-chemical and microbiological indicators of dry leaves of stevia (powder)
Name of indicatorMass fraction, %
Fraction of total mass of diterpene glycosides, %7,0
Mass fraction of moisture, %14,0
Mass fraction of brown and yellow leaves, %15,0
Mass fraction of impurities of vegetable origin, %1,0
Mass fraction of any impurities, %1,5
The presence of mold and rotNot allowed
The infestation of pests Not allowed
Microbiological indicators:
Knafaim, CFU/g, not more than2×106
Mold, CFU/g, not more than1×104
Pathogenic, including Salmonellanot allowed in 25 g
Mold, CFU/g, not more than1×104
BGK (coliforms)0,001

The safety performance of dry leaves of stevia (powder) are given in table 4.

Table 4
IndicatorsPermissible levels
Arsenic, mg/kg, not more than3,0
Lead, mg/kg, not more than5,0
Cadmium, mg/kg, not more than0,2
Radionuclides:
Cesium-137200
Strontium-90100

Information on food and energy value per 100 g dry

the leaves of the stevia plant are presented in table 5.

Table 5
Name of indicatorDry stevia leaf (powder)
Protein, kcal9,6
Fat, kcal8,46
Energy value, kcalto 28.05
kJ117,36

Table 6 shows the amino acid composition of dry leaves of stevia (powder).

The dry leaves of stevia (powder) contain essential and non-essential amino acids in balanced quantity and can be taken as biologically active plant ingredient for dry diet product mix.

Probiotics

For the prophylaxis of intestinal dysbacteriosis widely used probiotics biologically active substances, which are a new class of drugs and affect the body at the system level. Their influence affects the regulatory system, which is activated nonspecific resistance of the organism, the immune system.

Backpropagate and BAD, produced by biotechnological methods using living organisms use to stimulate nonspecific immunity, prevention and treatment of mixed gastro-intestinal infections, digestive disorders that occur due to various factors.

Dietary Supplement a dietary "Beobachten"

Acidophilus Lactobacillus in the form of SUPPLEMENTS "Beobachten", contain up to 109bacterial cells Lb. Acidophilus, strain 12 b (see THE 9229-054-07532800-2005, development of NIKIM Stavropol). This strain Lactobacillus acidophilus safe: contains live microorganisms that are "colonizing" the digestive tract and have the ability to inhibit or suppress the growth of bacteria that cause disorders of the gastrointestinal tract.

Mechanism of action BAD "Beobachten" fills a gap acidophilic Bacillus and has a high antagonistic activity against a wide spectrum of pathogenic and conditionally pathogenic microorganisms, leading to the displacement of the last of the microbiocenosis of intestines and create favorable conditions for normalization of microflora and functions of the digestive tract, metabolic processes.

Immunobiological preparation

"Bifidumbacterin dry lyophilisate

Representative of useful microflora are the bifidobacteria group Bifidobacterium bifidum. About the and have bifidogenic effect and provide the activation of the immune system, the formation of non-specific immune bodies, reduce the pH of the gut contents, create unfavorable conditions for the development of pathogenic microflora. Bifidobacterium Bifidobacterium bifidum presented in the form of immunobiological preparation "Bifidumbacterin dry lyophilisate" Fund 42-0092-2847-02, certificate of compliance No. 000452, OKP 01897209 produced by FSUE "NPO "Microgen" health Ministry.

Sharing of lactobacilli Lb. Acidophilus in the form of SUPPLEMENTS "Beobachten" and bifidobacteria group Bifidobacterium bifidum in the form of "Bifidumbacterin dry lyophilisate in combination with herbal dietary supplements in the form of powder of dry leaves of stevia for diet product mix provides the following benefits: normalization of microflora; the enrichment of the product biologically active vegetable ingredients and probiotic microorganisms.

The present invention in comparison with the prototype and other known technical solution has the following advantages: allows to reduce production costs, to increase the use of probiotic supplements containing bifido - and acidobacteria, dry leaves of stevia.

Diet product mix, including oatmeal and water, characterized in that it further comprises a powder of dry leaves of stevia, BAD "Beobachten" and "Bifidumbacterin dry lyophilisate(ratio 1:4) in the following ratio of components, wt.%:

Oatmeal94,0-95,0
Powder of dry leaves of stevia1,5-2,0
BAD "Beobachten" and "Bifidumbacterin dry"
the lyophilisate (ratio 1:4)1,5-2,0
WaterRest



 

Same patents:

FIELD: food industry.

SUBSTANCE: invention relates to a plastic edible composition ensuring a pleasant sensation in the mouth similar to that caused by chocolate melting in the mouth. The plastic edible composition includes: (a) starch blended with water at a weight ratio of starch to water 5:95 accordingly, at a temperature of 22°C the starch has viscosity from 0.03 to 2 Pa·s with a shear rate 10 sec-1, (b) a protein-containing component which essentially hydrates in water and does not coagulate, (c) a sweetener that, when essentially hydrated, is at least 90% free of crystals in the edible composition, (d) a fat-containing component which melts at a temperature of 45°C or less, (e) a gelating hydrocolloid agent facilitating formation of gel matrix which is destroyed at a temperature of 45°C or less and (f) an edible surfactant with HLB from 0 to 12. The edible composition has final moisture content 10 wt % - 50 wt % of total composition weight.

EFFECT: invention allows to produce a plastic edible composition ensuring chocolate sensation in the mouth but having lower caloricity in comparison with chocolate.

45 cl, 1 dwg, 15 tbl, 14 ex

FIELD: medicine, pharmaceutics.

SUBSTANCE: claimed are dietary and/or nutriceutic pharmaceutical composition for peroral application which contains S-adenosylmethi-onine-para-toluolsulfonate (SAMe) in combination with inositol and/or ino-sitol-1-phosphate and pharmaceutically acceptable excipients, in which at least one of and pharmaceutically acceptable excipients represents magnesium oxide in concentration from approximately 1.0 to approximately 10.0% of composition weight (versions), method of its obtaining, method of stabilisation of hard food and/or nutriceutic pharmaceutical composition based on SAMe-para-toluolsulfonate by application of inositol and/or inositol-1-phosphate, application of SAMe-para-toluolsulfonate in combination with inositol and/or inositol-1-phosphate for obtaining composition for treatment of depressive states and panic syndromes.

EFFECT: inclusion of magnesium oxide into composition increases SAMe-para-toluolsulfonate stability, inositol reduces SAMe-para-toluolsulfonate hygroscopicity and contributes to its soothing and antidepressant action.

27 cl, 41 tbl, 7 ex

FIELD: food industry.

SUBSTANCE: invention relates to food industry and, particularly, to prophylactic biologically active additives, in particular - those produced of vegetal raw material as well as to their production method. The biologically active additive contains a mixture of varied polyprenyl phosphates and/or polyprenyl pyrophosphates with 7-30 isoprene links absorbed on a solid sorbent such as sorbitol, lactose, starch. The method involves dissolution of a mixture of polyprenyl phosphates and/or polyprenyl pyrophosphates in an organic solvent, addition of a sorbent to the produced solution with subsequent stirring and solvent evaporation. Beta-sitosterin may be added together with the sorbent.

EFFECT: invention enables production of a biologically active additive for reduction of cholesterol content in blood, proteins glycosylation stimulation and prevention of infectious and cardiovascular diseases.

11 cl, 3 tbl, 6 ex

FIELD: food industry.

SUBSTANCE: invention relates to biologically active additives (BAA) production. BAA includes ascorbic acid, potato starch, calcium stearate, stearic acid, aerosil, a flavouring agent (identical to natural or natural) as well as a sweetening agent represented by fructose at the following components ratio, g per tablet weighting 0.57-3.2 g. ascorbic acid - 0.009250-0.0297; potato starch - 0.0285-0.1258; calcium stearate - 0.001-0.0116; stearic acid - 0.001-0.0116; aerosil - 0.002-0.0233; flavouring agent - 0.00114-0.0076; the rest is fructose. Alternatively the BAA sweetening agent may be represented by glucose at the following components ratio, g per tablet weighting 0.57-3.2 g: ascorbic acid - 0.00925-0.03547; potato starch - 0.0285-0.1258; calcium stearate - 0.001-0.0116; stearic acid - 0.001-0.0116; aerosil - 0.002-0.0233; flavouring agent - 0.00114-0.0076; the rest is glucose. Alternatively the BAA sweetening agent may be represented by a combination of sugar and glucose at the following components ratio, g per tablet weighting 2.6-3.2 g: ascorbic acid - 0.023-0.0297; sugar - 0.9045-1.2160, potato starch - 0.0936-0.1258; calcium stearate - 0.01305-0.0175; stearic acid - 0.01305-0.0175; aerosil - 0.0261-0.0351; flavouring agent - 0.00549-0.0076; the rest is glucose.

EFFECT: invention allows to cardinally enhance the tablets mechanical strength, improve their compressibility, ensure stable and long storage life (2 years) of BAA in the form of tablets, reduce the volume of processing deficiency due to tablet stratification in the process of production of BAA tablets.

6 cl

FIELD: food industry.

SUBSTANCE: invention relates to biologically active additives (BAA) production. BAA includes ascorbic acid, potato starch, calcium stearate, stearic acid, aerosil, a flavouring agent (identical to natural or natural) as well as a sweetening agent represented by fructose at the following components ratio, g per tablet weighting 0.57-3.2 g. ascorbic acid - 0.009250-0.0297; potato starch - 0.0285-0.1258; calcium stearate - 0.001-0.0116; stearic acid - 0.001-0.0116; aerosil - 0.002-0.0233; flavouring agent - 0.00114-0.0076; the rest is fructose. Alternatively the BAA sweetening agent may be represented by glucose at the following components ratio, g per tablet weighting 0.57-3.2 g: ascorbic acid - 0.00925-0.03547; potato starch - 0.0285-0.1258; calcium stearate - 0.001-0.0116; stearic acid - 0.001-0.0116; aerosil - 0.002-0.0233; flavouring agent - 0.00114-0.0076; the rest is glucose. Alternatively the BAA sweetening agent may be represented by a combination of sugar and glucose at the following components ratio, g per tablet weighting 2.6-3.2 g: ascorbic acid - 0.023-0.0297; sugar - 0.9045-1.2160, potato starch - 0.0936-0.1258; calcium stearate - 0.01305-0.0175; stearic acid - 0.01305-0.0175; aerosil - 0.0261-0.0351; flavouring agent - 0.00549-0.0076; the rest is glucose.

EFFECT: invention allows to cardinally enhance the tablets mechanical strength, improve their compressibility, ensure stable and long storage life (2 years) of BAA in the form of tablets, reduce the volume of processing deficiency due to tablet stratification in the process of production of BAA tablets.

6 cl

FIELD: food industry.

SUBSTANCE: invention relates to chemical and pharmaceutical and food industries and deals with a method for processing commercial Japanese sea cucumber (Cucumaria japonica) and a biologically active product produced by this method. The method involves milling cucumaria skin-muscular sac, its extraction with 96% ethyl alcohol under heating conditions, the extract separation, repeated extraction of the residue, supernatant separation by way of centrifugation and the extracts combination. Then the cucumaria tissue residue is air-dried at room temperature and vacuumised. Then the tissue residue is milled during 3-5 hours and strained through a sieve till the end product particles size is no more than 0.08 mm. The produced product has hepato-protective properties and contains the following basic components (wt %): protein- no less than 70, carbohydrates - 4.5-4.9, calcium - 1.5-1.9, sodium - 0.9-1.3, magnesium - 0.5-0.9, potassium - 0.2-0.6, alcohol - no more than 0.5%, moisture - no more than 10% and ashes - no more than 8%.

EFFECT: invention allows to more completely process a valuable biological raw material as well as manufacture a new product (being a source of indispensable amino acids and food fibres) used for prevention of toxic liver diseases.

3 cl, 3 dwg, 5 tbl, 5 ex

FIELD: food industry.

SUBSTANCE: invention relates to food industry. The composition for preparation of biologically active food additive contains wt %: cedar sap - 0.1-15.0, the rest is oily base. The oily base may be represented by cedar nut oil and/or linseed oil and/or a sea-buckthorn fruits oil concentrate in any combination. The composition containing cedar nut oil as the oily base includes a functional component represented by cedar sap in an amount of 0.1 - 5.0 wt % or more than 12.5 but up to 15.0 wt % inclusive.

EFFECT: invention allows to produce a new food additive with enhanced biologically activity due to enhancement and optimisation of the content of polyunsaturated fatty acids, sterines and terpenes as well as due to the resorptive properties of terpenes with regard to the biologically active composition components.

6 tbl, 4 ex

FIELD: medicine.

SUBSTANCE: method of intestine flora modification in animals with inflammatory disease of intestine (IDI) or subjected to risk of IDI development, includes introduction to animal of composition which includes, at least, one antioxidant. Antioxidant is selected from group, consisting of vitamin E, as general tocopherol, in amount from approximately 50 to approximately 1000 mcg, vitamin C in amount from approximately 30 to approximately 400 mcg and β-carotene in amount from approximately 0.1 to approximately 5 mcg per gram of feeding stuff consumed by animal in terms of dry substance. Also by introduction of said composition to animal realised is method of reduction of inflammation in gastro-intestinal tract of animal. Also claimed are set, composition of feeding stuff and combination of feeding stuff composition and, at least, one probiotic and prebiotic.

EFFECT: inventions ensure improvement of balance of useful and harmful bacteria in gastro-intestinal tract of animal.

35 cl, 4 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: method of intestine flora modification in animals with inflammatory disease of intestine (IDI) or subjected to risk of IDI development, includes introduction to animal of composition which includes, at least, one antioxidant. Antioxidant is selected from group, consisting of vitamin E, as general tocopherol, in amount from approximately 50 to approximately 1000 mcg, vitamin C in amount from approximately 30 to approximately 400 mcg and β-carotene in amount from approximately 0.1 to approximately 5 mcg per gram of feeding stuff consumed by animal in terms of dry substance. Also by introduction of said composition to animal realised is method of reduction of inflammation in gastro-intestinal tract of animal. Also claimed are set, composition of feeding stuff and combination of feeding stuff composition and, at least, one probiotic and prebiotic.

EFFECT: inventions ensure improvement of balance of useful and harmful bacteria in gastro-intestinal tract of animal.

35 cl, 4 tbl, 2 ex

FIELD: medicine.

SUBSTANCE: method of intestine flora modification in animals with inflammatory disease of intestine (IDI) or subjected to risk of IDI development, includes introduction to animal of composition which includes, at least, one antioxidant. Antioxidant is selected from group, consisting of vitamin E, as general tocopherol, in amount from approximately 50 to approximately 1000 mcg, vitamin C in amount from approximately 30 to approximately 400 mcg and β-carotene in amount from approximately 0.1 to approximately 5 mcg per gram of feeding stuff consumed by animal in terms of dry substance. Also by introduction of said composition to animal realised is method of reduction of inflammation in gastro-intestinal tract of animal. Also claimed are set, composition of feeding stuff and combination of feeding stuff composition and, at least, one probiotic and prebiotic.

EFFECT: inventions ensure improvement of balance of useful and harmful bacteria in gastro-intestinal tract of animal.

35 cl, 4 tbl, 2 ex

FIELD: food industry.

SUBSTANCE: invention refers to fat-and-oil industry. Pollen or ambrosia is dissolved in 3% acetic acid solution. One separately mills salt and sugar sand with egg yolk. Then one adds the dissolute pollen or ambrosia to the mixture, stirs it and gradually introduces deodorised refined vegetable oil. The mixture is homogenised from 2 to 5 minutes to produce a homogeneous mass. The components are used at the following weight ratio %: deodorised refined vegetable oil - 60, egg yolk - 20, sugar sand - 2, salt - 3, 3% acetic acid - 10, pollen or ambrosia - 5.

EFFECT: invention allows to produce a functional-purpose mayonnaise enriched with pollen or with a product of it (ambrosia) containing indispensable amino acids, a large quantity of vitamins and enzymes with antimicrobial properties and biological value.

2 tbl, 1 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum 79-40 strain is recovered from bowels of a healthy adult and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 238. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass. The Bifidobacterium adolescentis 79-40 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk.

EFFECT: availability of the strain for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum DVA-11 strain is recovered from bowels of a healthy adult and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 225. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass. The Bifidobacterium adolescentis DVA-11 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity.

EFFECT: availability of the Bifidobacterium bifidum DVA-11 strain for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum 79-11 strain is recovered from bowels of a healthy infant and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 240. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass in short cultivation time 12-24 h. The Bifidobacterium adolescentis 79-11 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk.

EFFECT: availability of the strain for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium longum 79-67 strain is recovered from bowels of a healthy infant and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 233. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass. The Bifidobacterium adolescentis 79-67 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity.

EFFECT: availability of the Bifidobacterium longum 79-67 strain for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum 79-75 strain is recovered from bowels of a healthy infant and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 247. The strain actively propagates in nutrient mediums of various compositions with accumulating a high bifidus bacteria process biomass in short cultivation time 12-24 h. The Bifidobacterium adolescentis 79-75 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk.

EFFECT: availability of the Bifidobacterium bifidum 79-75 strain for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum DVA-12 strain is recovered from bowels of a healthy adult and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 224. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass.

EFFECT: Bifidobacterium bifidum DVA-12 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk that enables to use it for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum 79-33 strain is recovered from bowels of a healthy infant and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 241. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass in short cultivation time 12-24 h.

EFFECT: Bifidobacterium bifidum 79-33 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk that enables to use it for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium adolescentis 79-34 strain is recovered from bowels of a healthy infant and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 237. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass.

EFFECT: Bifidobacterium bifidum 79-34 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk that enables to use it for preparing bifidus products.

2 tbl, 5 ex

FIELD: medicine.

SUBSTANCE: Bifidobacterium bifidum 79-86 strain is recovered from bowels of a healthy infant and deposited in the State collection of microorganisms of the normal flora (SCNF) of Federal State Research Institution Gabrichevskiy Moscow Research Institution of Epidemiology and Microbiology of Federal Service for Supervision of Consumer Rights and Human Welfare, No. 204. The strain actively propagates in various nutrient mediums with accumulating a high bifidus bacteria process biomass in short cultivation time 12-24 h.

EFFECT: Bifidobacterium bifidum 79-86 strain exhibits acid-forming activity, pathogen and opportunistic pathogen antagonist activity, ferments milk that enables to use it for preparing bifidus products.

2 tbl, 5 ex

Dietary product // 2413431

FIELD: food industry.

SUBSTANCE: invention relates to production, processing and biotechnology of agricultural produce, is intended for use in dietary nutrition and development of biotechnological methods to produce functional products of new generation for animals. Substance of invention consists in mixing of the following components in dry form, wt %: oat flour 93.0-96.0, biologically active supplement "Biobaction" - 3.0-4.0, powder of dry stevia leaves - 1.0-3.0.

EFFECT: invention makes it possible to develop product balanced in nutrient and biological value, to reduce costs for production, to expand use of biologically active components: probiotics in the form of biologically active supplement "Biobaction" and vegetable ones in the form of dry stevia leaves.

5 tbl, 4 ex

Up!